D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Amazon
AMZN
|
+$1.02B |
| 2 |
Tesla
TSLA
|
+$451M |
| 3 |
Wells Fargo
WFC
|
+$433M |
| 4 |
Procter & Gamble
PG
|
+$359M |
| 5 |
Meta Platforms (Facebook)
META
|
+$342M |
Top Sells
| 1 |
Shopify
SHOP
|
+$523M |
| 2 |
Adobe
ADBE
|
+$373M |
| 3 |
DocuSign
DOCU
|
+$312M |
| 4 |
Exxon Mobil
XOM
|
+$285M |
| 5 |
Citigroup
C
|
+$260M |
Sector Composition
| 1 | Technology | 22.42% |
| 2 | Consumer Discretionary | 14.18% |
| 3 | Healthcare | 12.61% |
| 4 | Financials | 9.46% |
| 5 | Communication Services | 6.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
iRobot
IRBT
$106M
| $40.3M | 0.05% |
480,200
+325,941
| +211% | +$27.3M |
|
302
Parker-Hannifin
PH
$95.7B
| $39.8M | 0.05% |
217,290
-126,540
| -37% | -$23.2M |
|
303
ATI
ATI
$10.3B
| $39.6M | 0.05% |
3,887,285
+2,086,190
| +116% | +$21.3M |
|
|
DHR.PRA
304
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $39.5M | 0.05% |
31,500
+11,500
| +58% | +$14.4M |
|
|
AMRN
305
Amarin Corp
AMRN
$315M
| $39.4M | 0.05% |
284,928
+281,043
| +7,234% | +$38.9M |
|
306
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.9B
| $39.4M | 0.05% |
482,351
-691,907
| -59% | -$56.5M |
|
|
DFS
307
DELISTED
Discover Financial Services
DFS
| $39.2M | 0.05% |
782,059
+535,074
| +217% | +$26.8M |
|
308
Centene
CNC
$15.3B
| $39.1M | 0.05% |
615,546
+602,332
| +4,558% | +$38.3M |
|
|
CCI.PRA
309
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $39.1M | 0.05% |
26,264
+11,764
| +81% | +$17.5M |
|
310
Henry Schein
HSIC
$8.2B
| $39.1M | 0.05% |
668,833
-802,583
| -55% | -$46.9M |
|
311
O'Reilly Automotive
ORLY
$90.7B
| $38.8M | 0.05% |
1,379,925
+721,350
| +110% | +$20.3M |
|
312
Ingevity
NGVT
$2.14B
| $38.7M | 0.05% |
735,657
+50,970
| +7% | +$2.68M |
|
313
Williams-Sonoma
WSM
$24.7B
| $38.7M | 0.05% |
943,000
+421,424
| +81% | +$17.3M |
|
314
Plains GP Holdings
PAGP
$3.66B
| $38.6M | 0.05% |
4,340,834
+1,142,932
| +36% | +$10.2M |
|
315
Invitation Homes
INVH
$18.6B
| $38.6M | 0.05% |
1,400,391
-2,012,268
| -59% | -$55.4M |
|
316
PG&E
PCG
$32.9B
| $38.4M | 0.05% |
+4,331,344
| New | +$38.4M |
|
317
Estee Lauder
EL
$31.9B
| $38.1M | 0.05% |
201,764
+95,798
| +90% | +$18.1M |
|
|
NKLAW
318
DELISTED
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
| $38.1M | 0.05% |
+1,146,106
| New | +$38.1M |
|
319
Elanco Animal Health
ELAN
$9.32B
| $38M | 0.05% |
1,772,507
-1,406,462
| -44% | -$30.2M |
|
320
Citizens Financial Group
CFG
$22.3B
| $38M | 0.05% |
1,503,905
-513,282
| -25% | -$13M |
|
321
Editas Medicine
EDIT
$248M
| $37.8M | 0.05% |
1,276,641
+233,592
| +22% | +$6.91M |
|
322
Commault Systems
CVLT
$8.23B
| $37.4M | 0.04% |
967,294
-128,819
| -12% | -$4.99M |
|
323
Workiva
WK
$4.32B
| $37.3M | 0.04% |
697,792
+155,080
| +29% | +$8.3M |
|
324
HF Sinclair
DINO
$9.81B
| $37.3M | 0.04% |
1,277,732
+311,545
| +32% | +$9.1M |
|
325
Myriad Genetics
MYGN
$649M
| $37.3M | 0.04% |
3,289,330
+609,172
| +23% | +$6.91M |
|